Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain

Journal of Steroid Biochemistry and Molecular Biology

Volumn 103, Issue 3-5, 2007, Pages 538-545

  Eyles, D ^a,b   Almeras, L ^c   Benech, P ^d   Patatian, A ^d   Mackay Sim, A ^a,e   McGrath, J ^a,b   Feron F ^a,c,e  

^a QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Mediterranée University   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e GRIFFITH UNIVERSITY   (Australia)

Author keywords

Brain development; Cytoskeleton; Gene array; Hypovitaminosis D; Mitochondria; Rat; Synapse

Indexed keywords

CALCIUM; CHAPERONE; CYTOSKELETON PROTEIN; MITOCHONDRIAL PROTEIN; SYNAPSE RECEPTOR; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DYSFUNCTION; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; CYTOSKELETON; DIET; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; MALE; MATERNAL NUTRITION; MICROARRAY ANALYSIS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PROGENY; RAT; SCHIZOPHRENIA; TRANSLATION INITIATION; UNINDEXED SEQUENCE; VITAMIN D DEFICIENCY;

AGING; ANIMALS; BRAIN; CYTOSKELETON; FEMALE; GENE EXPRESSION REGULATION; MALE; MITOCHONDRIA; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TIME FACTORS; TRANSCRIPTION, GENETIC; VITAMIN D DEFICIENCY;

ANIMALIA; RATTUS;

EID: 33947119198     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.12.096     Document Type: Article

References (44)

1. Stumpf W.E., Sar M., Clark S.A., and DeLuca H.F. Brain target sites for 1,25-dihydroxyvitamin D3. Science 215 4538 (1982) 1403
2. 2 vitamin D3 sites of action in spinal cord and sensory ganglion. Anat. Embryol. (Berl.) 177 4 (1988) 307
3. Eyles D.W., Smith S., Kinobe R., Hewison M., and McGrath J.J. Distribution of the Vitamin D receptor and 1alpha-hydroxylase in human brain. J. Chem. Neuroanat. 29 1 (2005) 21
4. Peterlik M., and Cross H.S. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur. J. Clin. Invest. 35 5 (2005) 290
5. McGrath J. Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia?. Schizophr. Res. 40 3 (1999) 173
6. McGrath J. Does 'imprinting' with low prenatal vitamin D contribute to the risk of various adult disorders?. Med. Hypotheses 56 3 (2001) 367
7. Chaudhuri A. Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med. Hypotheses 64 3 (2005) 608
8. Willer C.J., Dyment D.A., Sadovnick A.D., Rothwell P.M., Murray T.J., and Ebers G.C. Timing of birth and risk of multiple sclerosis: population based study. BMJ 330 7483 (2005) 120 Epub December 7, 2004
9. McGrath J., Saari K., Hakko H., Jokelainen J., Jones P., Jarvelin M.R., Chant D., and Isohanni M. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr. Res. 67 2/3 (2004) 237
10. McGrath J., Eyles D., Mowry B., Yolken R., and Buka S. Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophr. Res. 63 1/2 (2003) 73
11. Eyles D., Brown J., Mackay-Sim A., McGrath J., and Feron F. Vitamin D3 and brain development. Neuroscience 118 3 (2003) 641
12. Feron F., Burne T.H., Brown J., Smith E., McGrath J.J., Mackay-Sim A., and Eyles D.W. Developmental Vitamin D(3) deficiency alters the adult rat brain. Brain Res. Bull. 65 2 (2005) 141
13. Burne T.H., Becker A., Brown J., Eyles D.W., Mackay-Sim A., and McGrath J.J. Transient prenatal Vitamin D deficiency is associated with hyperlocomotion in adult rats. Behav. Brain. Res. 154 2 (2004) 549
14. Becker A., Eyles D.W., McGrath J.J., and Grecksch G. Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats. Behav. Brain. Res. 161 2 (2005) 306
15. Hosack D.A., Dennis Jr. G., Sherman B.T., Lane H.C., and Lempicki R.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 4 10 (2003) R70 Epub September 11, 2003
16. Nemere I., Safford S.E., Rohe B., DeSouza M.M., and Farach-Carson M.C. Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS) binding protein. J. Steroid Biochem. Mol. Biol. 89/90 1-5 (2004) 281
17. Nemere I., Ray R., and McManus W. Immunochemical studies on the putative plasmalemmal receptor for 1,25(OH)(2)D(3). I. Chick intestine. Am. J. Physiol. Endocrinol. Metab. 278 6 (2000) E1104
18. Murthy M.S., and Pande S.V. A stress-regulated protein, GRP58, a member of thioredoxin superfamily, is a carnitine palmitoyltransferase isoenzyme. Biochem. J. 304 Pt 1 (1994) 31
19. Boyan B.D., and Schwartz Z. Rapid vitamin D-dependent PKC signaling shares features with estrogen-dependent PKC signaling in cartilage and bone. Steroids 69 8/9 (2004) 591
20. Chou S.Y., Hannah S.S., Lowe K.E., Norman A.W., and Henry H.L. Tissue-specific regulation by vitamin D status of nuclear and mitochondrial gene expression in kidney and intestine. Endocrinology 136 12 (1995) 5520
21. Baudet C., Perret E., Delpech B., Kaghad M., Brachet P., Wion D., and Caput D. Differentially expressed genes in C6.9 glioma cells during vitamin D-induced cell death program. Cell Death Differ. 5 1 (1998) 116
22. Lin R., Nagai Y., Sladek R., Bastien Y., Ho J., Petrecca K., Sotiropoulou G., Diamandis E.P., Hudson T.J., and White J.H. Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol. Endocrinol. 16 6 (2002) 1243
23. Katayama M.L., Pasini F.S., Folgueira M.A., Snitcovsky I.M., and Brentani M.M. Molecular targets of 1,25(OH)2D3 in HC11 normal mouse mammary cell line. J. Steroid Biochem. Mol. Biol. 84 1 (2003) 57
24. Swami S., Raghavachari N., Muller U.R., Bao Y.P., and Feldman D. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res. Treat. 80 1 (2003) 49
25. Li X., Zheng W., and Li Y.C. Altered gene expression profile in the kidney of vitamin D receptor knockout mice. J. Cell. Biochem. 89 4 (2003) 709
26. Spach K.M., Pedersen L.B., Nashold F.E., Kayo T., Yandell B.S., Prolla T.A., and Hayes C.E. Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiol. Genomics 18 2 (2004) 141
27. Kutuzova G.D., and Deluca H.F. Gene expression profiles in rat intestine identify pathways for 1,25-dihydroxyvitamin D(3) stimulated calcium absorption and clarify its immunomodulatory properties. Arch. Biochem. Biophys. 432 2 (2004) 152
28. Wang T.T., Tavera-Mendoza L.E., Laperriere D., Libby E., MacLeod N.B., Nagai Y., Bourdeau V., Konstorum A., Lallemant B., Zhang R., Mader S., and White J.H. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol. Endocrinol. 19 11 (2005) 2685
29. Fujimoto T., Nakano T., Takano T., Hokazono Y., Asakura T., and Tsuji T. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging. Acta Psychiatr. Scand. 86 6 (1992) 455
30. Volz H.R., Riehemann S., Maurer I., Smesny S., Sommer M., Rzanny R., Holstein W., Czekalla J., and Sauer H. Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study. Biol. Psychiatry 47 11 (2000) 954
31. Uranova N.A., and Aganova E.A. Ultrastructure of the synapses of the anterior limbic cortex in schizophrenia. Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova 89 7 (1989) 56
32. Kung L., and Roberts R.C. Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse 31 1 (1999) 67
33. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T., Griffin J.L., Wayland M., Freeman T., Dudbridge F., Lilley K.S., Karp N.A., Hester S., Tkachev D., Mimmack M.L., Yolken R.H., Webster M.J., Torrey E.F., and Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 9 7 (2004) 684
34. Lu F., Selak M., O'Connor J., Croul S., Lorenzana C., Butunoi C., and Kalman B. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 177 2 (2000) 95
35. Lampert P., and Carpenter S. Electron microscopic studies on the vascular permeability and the mechanism of demyelination in experimental allergic encephalomyelitis. J. Neuropathol. Exp. Neurol. 24 (1965) 11
36. Mutsaers S.E., and Carroll W.M. Focal accumulation of intra-axonal mitochondria in demyelination of the cat optic nerve. Acta Neuropathol. (Berl.) 96 2 (1998) 139
37. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., and Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28 1 (2000) 53
38. Holz A., Bielekova B., Martin R., and Oldstone M.B. Myelin-associated oligodendrocytic basic protein: identification of an encephalitogenic epitope and association with multiple sclerosis. J. Immunol. 164 2 (2000) 1103
39. Kaye J.F., Kerlero de Rosbo N., Mendel I., Flechter S., Hoffman M., Yust I., and Ben-Nun A. The central nervous system-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS). J. Neuroimmunol. 102 2 (2000) 189
40. de Rosbo N.K., Kaye J.F., Eisenstein M., Mendel I., Hoeftberger R., Lassmann H., Milo R., and Ben-Nun A. The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501. J. Immunol. 173 2 (2004) 1426
41. Almeras L., Lefranc D., Drobecq H., de Seze J., Dubucquoi S., Vermersch P., and Prin L. New antigenic candidates in multiple sclerosis: identification by serological proteome analysis. Proteomics 4 7 (2004) 2184
42. Bateson P., Barker D., Clutton-Brock T., Deb D., D'Udine B., Foley R.A., Gluckman P., Godfrey K., Kirkwood T., Lahr M.M., McNamara J., Metcalfe N.B., Monaghan P., Spencer H.G., and Sultan S.E. Developmental plasticity and human health. Nature 430 6998 (2004) 419
43. Gluckman P.D., and Hanson M.A. The developmental origins of the metabolic syndrome. Trends Endocrinol. Metab. 15 4 (2004) 183
44. Waterland R.A., and Jirtle R.L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell. Biol. 23 15 (2003) 5293